The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I/II study of nivolumab and axitinib in patients with advanced renal cell carcinoma.
 
Matthew R. Zibelman
Honoraria - Pfizer
Consulting or Advisory Role - EMD Serono; Exelixis; Horizon Pharma; Janssen; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Exelixis (Inst); Horizon Pharma (Inst); Pfizer (Inst)
Other Relationship - Association of Community Cancer Centers (ACCC)
 
Michael Anthony Carducci
Consulting or Advisory Role - Exelixis; Foundation Medicine; Pfizer; Roche/Genentech
Research Funding - Arcus Biosciences (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); pfizer (Inst)
 
Yasser Ged
No Relationships to Disclose
 
Ana M. Molina
Consulting or Advisory Role - Eisai; Eisai; Eisai; Exelixis; Janssen
 
Rahul Ravilla
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb/Celgene; Seattle Genetics/Astellas
Speakers' Bureau - Bristol-Myers Squibb/Celgene
 
David R. Shaffer
No Relationships to Disclose
 
Courtney Lambert
No Relationships to Disclose
 
Mahvish Tafseer
No Relationships to Disclose
 
Rachel Basiura
No Relationships to Disclose
 
Danielle Weismann
No Relationships to Disclose
 
Rutika Kokate
No Relationships to Disclose
 
Karthik Devarajan
No Relationships to Disclose
 
Karen Ruth
No Relationships to Disclose
 
R. Katherine Alpaugh
Research Funding - Merck
Patents, Royalties, Other Intellectual Property - An inflammatory breast cancer cell line was established and is being provided by Fox Chase Cancer Center for research purposes. Royalties are received yearly dependent on the number of requests.
 
Fern Anari
No Relationships to Disclose
 
Pooja Ghatalia
Research Funding - AstraZeneca (Inst); Bristol Myers Squibb Foundation (Inst); Merck (Inst)
 
Daniel M. Geynisman
Consulting or Advisory Role - 2nd.MD; AstraZeneca; Eisai; Exelixis; Merck; Myovant Sciences; Pfizer; Seattle Genetics/Astellas
Research Funding - Astellas Pharma (Inst); Calithera Biosciences (Inst); Genentech (Inst); Harpoon therapeutics (Inst); Merck (Inst)
 
Elizabeth R. Plimack
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Flatiron Health; Genentech/Roche; Infinity Pharmaceuticals; Janssen; MEI Pharma; Merck; Pfizer; Seagen
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Merck Sharp & Dohme (Inst); Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - U.S. Patent No.: 14/588,503, Filed 1/2/2015. (Inst)